Neurocrine Biosciences (NBIX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $174.26 +3.87%
Revenue Growth %: +27.0%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
CRMT, More
Revenue Growth %: +27.0%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.07), $0.10 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
